NM_005076.5:c.223A>G

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1

The NM_005076.5(CNTN2):​c.223A>G​(p.Met75Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0004 in 1,590,434 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00047 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00039 ( 1 hom. )

Consequence

CNTN2
NM_005076.5 missense

Scores

2
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.773

Publications

3 publications found
Variant links:
Genes affected
CNTN2 (HGNC:2172): (contactin 2) This gene encodes a member of the contactin family of proteins, part of the immunoglobulin superfamily of cell adhesion molecules. The encoded glycosylphosphatidylinositol (GPI)-anchored neuronal membrane protein plays a role in the proliferation, migration, and axon guidance of neurons of the developing cerebellum. A mutation in this gene may be associated with adult myoclonic epilepsy. [provided by RefSeq, Sep 2016]
CNTN2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • epilepsy, familial adult myoclonic, 5
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • benign adult familial myoclonic epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0061230958).
BP6
Variant 1-205058188-A-G is Benign according to our data. Variant chr1-205058188-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 581019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000473 (72/152264) while in subpopulation AMR AF = 0.000261 (4/15302). AF 95% confidence interval is 0.0000887. There are 0 homozygotes in GnomAd4. There are 38 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTN2NM_005076.5 linkc.223A>G p.Met75Val missense_variant Exon 4 of 23 ENST00000331830.7 NP_005067.1 Q02246A1ML24A1L3A3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTN2ENST00000331830.7 linkc.223A>G p.Met75Val missense_variant Exon 4 of 23 1 NM_005076.5 ENSP00000330633.4 Q02246

Frequencies

GnomAD3 genomes
AF:
0.000473
AC:
72
AN:
152146
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.0164
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000733
AC:
167
AN:
227740
AF XY:
0.000709
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000222
Gnomad ASJ exome
AF:
0.0165
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000183
Gnomad OTH exome
AF:
0.00128
GnomAD4 exome
AF:
0.000392
AC:
564
AN:
1438170
Hom.:
1
Cov.:
32
AF XY:
0.000385
AC XY:
275
AN XY:
713394
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32806
American (AMR)
AF:
0.000216
AC:
9
AN:
41682
Ashkenazi Jewish (ASJ)
AF:
0.0156
AC:
380
AN:
24408
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39494
South Asian (SAS)
AF:
0.0000122
AC:
1
AN:
81946
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52286
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5654
European-Non Finnish (NFE)
AF:
0.0000845
AC:
93
AN:
1100538
Other (OTH)
AF:
0.00136
AC:
81
AN:
59356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
31
62
92
123
154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000473
AC:
72
AN:
152264
Hom.:
0
Cov.:
32
AF XY:
0.000510
AC XY:
38
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41552
American (AMR)
AF:
0.000261
AC:
4
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0164
AC:
57
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68016
Other (OTH)
AF:
0.00142
AC:
3
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000802
Hom.:
0
Bravo
AF:
0.000540
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000930
AC:
8
ExAC
AF:
0.000544
AC:
66

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CNTN2: BP4, BS1 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

CNTN2-related disorder Benign:1
Jul 10, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Epilepsy, familial adult myoclonic, 5 Benign:1
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
16
DANN
Benign
0.93
DEOGEN2
Benign
0.10
T;T;.
Eigen
Benign
-0.39
Eigen_PC
Benign
-0.14
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.88
.;.;D
M_CAP
Benign
0.0075
T
MetaRNN
Benign
0.0061
T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
-0.63
N;N;.
PhyloP100
0.77
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-1.0
.;N;.
REVEL
Benign
0.074
Sift
Benign
0.23
.;T;.
Sift4G
Benign
0.59
.;T;.
Polyphen
0.0060
B;B;.
Vest4
0.11
MVP
0.59
MPC
0.43
ClinPred
0.021
T
GERP RS
5.3
Varity_R
0.23
gMVP
0.59
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144767577; hg19: chr1-205027316; API